Trinity Biotech | TRIB - Interest Expense On Debt


Trinity Biotech reported $3.33M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Abbott USD 68M 26M Mar/2026
Bayer EUR 675M 87M Dec/2025
Bio-Rad Laboratories USD 12.3M 100K Sep/2025
EDAP TMS EUR 49K 8K Sep/2025
J&J USD 43M 25M Mar/2026
Mesa Laboratories USD 3.02M 180K Sep/2024
OraSure Technologies 1.67M 1.13M Dec/2025
Plus Therapeutics USD 62K 25K Dec/2023
Roche Holding CHF 304M 7.5M Jun/2025
Siemens EUR 435M 1000K Dec/2025
Surmodics USD 884K 5K Sep/2024
Thermo Fisher Scientific USD 354M 11M Mar/2026
Tosoh JPY 884M 65M Sep/2025
Trinity Biotech USD 3.33M 50K Sep/2025
Veracyte USD 2K 1000 Dec/2023